As the Bioresorbable Scaffolds Market matures, the focus is shifting toward long-term clinical safety. Real-world evidence is beginning to substantiate the theoretical advantages of these scaffolds. By removing the need for a permanent cage inside the artery, clinicians are finding that patients experience fewer instances of late-stage cardiovascular events. This clinical success is driving...